Please login to the form below

Not currently logged in


This page shows the latest Sarclisa news and features for those working in and with pharma, biotech and healthcare.

Sanofi reveals $330m collaboration with Blackstone Life Sciences

Sanofi reveals $330m collaboration with Blackstone Life Sciences

treat patients with multiple myeloma, focusing on the subcutaneous formulation and delivery of the anti-CD38 antibody Sarclisa (isatuximab). ... Sarclisa is a monoclonal antibody that targets a specific epitope on the CD38 receptor on multiple myeloma

Latest news

More from news
Approximately 5 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts


Add my company

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...